EFFECTS OF VALBENAZINE ON TARDIVE DYSKINESIA AFTER TREATMENT WITHDRAWAL

被引：0
|
作者：
Jimenez, R. [1 ]
Cicero, S. [1 ]
Bron, M. [1 ]
Shah, C. [1 ]
Angelov, A. S. [1 ]
机构：
[1] Neurocrine Biosci Inc, San Diego, CA USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
POSB31
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [41] Valbenazine for tardive dyskinesia: a systematic review and network meta-analysis
    Kishi, Taro
    Sakuma, Kenji
    Iwata, Nakao
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2023, 38 (06) : 369 - 374
  • [42] Effects of Concomitant Medication Use on Tardive Dyskinesia Outcomes in Long-Term Valbenazine Trials
    Comella, Cynthia
    Singer, Carlos
    Kane, John
    Farahmand, Khodayar
    Burke, Joshua
    Siegert, Scott
    NEUROLOGY, 2019, 92 (15)
  • [43] Tardive Dyskinesia With Chorea-Ballism Improved by Valbenazine: A Case Report
    Ichihashi, Shinichi
    Iha, Akihiro
    Yasumura, Saori
    Kariya, Shingo
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [44] Improvement of tardive dyskinesia after treatment with olanzapine
    Truöl, S
    von Hippel, C
    Raape, J
    König, F
    PSYCHIATRISCHE PRAXIS, 2002, 29 (06) : 315 - 317
  • [45] LONG-TERM COST-EFFECTIVENESS OF VALBENAZINE AND DEUTETRABENAZINE FOR TARDIVE DYSKINESIA
    Harrigan, K.
    Walton, S. M.
    Huang, S. P.
    Kumar, V. M.
    Chapman, R. H.
    Atlas, S. J.
    Agboola, F. O.
    Ollendorf, D. A.
    Touchette, D. R.
    VALUE IN HEALTH, 2018, 21 : S184 - S184
  • [46] LONG-TERM TREATMENT WITH VALBENAZINE 40 MG ONCE-DAILY IN ADULTS WITH TARDIVE DYSKINESIA
    Chepke, C.
    Marder, S. R.
    Comella, C. L.
    Singer, C.
    Farahmand, K.
    Shah, C.
    Lundt, L.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E119 - E120
  • [47] Tardive dyskinesia with clozapine dose reduction or withdrawal dyskinesia? Reply
    Singh, Harminder
    Dulhani, Navin
    Kumar, Bithika Nel
    Singh, Prabhakar
    Tiwari, Pawan
    INDIAN JOURNAL OF PHARMACOLOGY, 2011, 43 (01): : 95 - 95
  • [48] Effects of Concomitant Medication Use on Tardive Dyskinesia Outcomes in a Long-Term Rollover Study of Valbenazine
    Farahmand, Khody
    Lindenmayer, Jean-Pierre
    Marder, Stephen
    Verghese, Cherian
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 338 - 338
  • [49] The Effects of Valbenazine in Participants with Tardive Dyskinesia: Results of the 1-Year KINECT 3 Extension Study
    Factor, Stewart A.
    Remington, Gary
    Comella, Cynthia L.
    Correll, Christoph U.
    Burke, Joshua
    Jimenez, Roland
    Liang, Grace S.
    O'Brien, Christopher F.
    JOURNAL OF CLINICAL PSYCHIATRY, 2017, 78 (09) : 1344 - +
  • [50] EVALUATION OF GLOBAL IMPROVEMENT AND LIFETIME COSTS OF TREATING TARDIVE DYSKINESIA SHOWS TREATMENT WITH VALBENAZINE DOMINATES DEUTETRABENAZINE
    Ganz, M.
    Stern, S.
    Chavan, A.
    Serbin, M.
    Yonan, C.
    VALUE IN HEALTH, 2019, 22 : S275 - S275
12345